Influenza vaccine

Human monoclonal antibodies show promise as treatment and prevention for influenza B

by

Researchers at Vanderbilt University Medical Center (VUMC) have made a significant breakthrough by isolating human monoclonal antibodies against influenza B. This virus is a notable public health threat, particularly affecting children, the elderly, and individuals with weakened immune systems. While seasonal flu vaccines provide coverage against both influenza A and B, they do not always … Read more

Novel recombinant influenza vaccine showspromise in animal studies

by

Recombinant protein vaccines, exemplified by the Novavax vaccine deployed in combating COVID-19, present a plethora of advantages over traditional vaccines. Their precise manufacturability, coupled with enhanced safety and potential efficacy, as well as the prospect of reduced dosage requirements, underscores their pivotal role in modern immunization strategies. Given these attributes, there is burgeoning interest in … Read more